GSTM1, GSTT1, GSTP1, and GSTA1 genetic variants are not associated with coronary artery disease in Taiwan

Gene

Volumn 523, Issue 1, 2013, Pages 64-69

  Yeh, Hseng Long ^a,b   Kuo, Li Tang ^c   Sung, Fung Chang ^d   Chiang, Cheng Wen ^a   Yeh, Chih Ching ^a,d  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b CATHAY GENERAL HOSPITAL   (Taiwan)

^c KEELUNG HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Coronary artery disease; Glutathione S transferase; Polymorphisms

Indexed keywords

CHOLESTEROL; GLUTATHIONE TRANSFERASE A1; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ALCOHOL CONSUMPTION; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; NULL ALLELE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING; TAIWAN;

AGED; COHORT STUDIES; CONFIDENCE INTERVALS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SMOKING; TAIWAN;

EID: 84877804176     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.02.052     Document Type: Article

References (56)

1. Albert R.E., et al. Effect of carcinogens on chicken atherosclerosis. Cancer Res. 1977, 37:2232-2235.
2. Ali-Osman F., et al. Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J. Biol. Chem. 1997, 272:10004-10012.
3. Anttila S., et al. Pulmonary expression of glutathione S-transferase M3 in lung cancer patients: association with GSTM1 polymorphism, smoking, and asbestos exposure. Cancer Res. 1995, 55:3305-3309.
4. Barreirinho S., et al. Inherited and acquired risk factors and their combined effects in pediatric stroke. Pediatr. Neurol. 2003, 28:134-138.
5. Bonomini F., et al. Atherosclerosis and oxidative stress. Histol. Histopathol. 2008, 23:381-390.
6. Botto N., et al. Evidence for DNA damage in patients with coronary artery disease. Mutat. Res. 2001, 493:23-30.
7. Chen X., et al. Glutathione S-transferase P1 gene Ile105Val polymorphism might be associated with lung cancer risk in the Chinese Han population. Tumour Biol. 2012, 33:1973-1981.
8. Coles B., et al. The role of human glutathione S-transferases (hGSTs) in the detoxification of the food-derived carcinogen metabolite N-acetoxy-PhIP, and the effect of a polymorphism in hGSTA1 on colorectal cancer risk. Mutat. Res. 2001, 482:3-10.
9. Coles B.F., et al. Effect of polymorphism in the human glutathione S-transferase A1 promoter on hepatic GSTA1 and GSTA2 expression. Pharmacogenetics 2001, 11:663-669.
10. Department of Health Health and Vital Statistics 2007, Department of Health, Executive Yuan, Taipei.
11. Dhalla N.S., et al. Role of oxidative stress in cardiovascular diseases. J. Hypertens. 2000, 18:655-673.
12. Doney A.S., et al. Increased cardiovascular morbidity and mortality in type 2 diabetes is associated with the glutathione S transferase theta-null genotype: a Go-DARTS study. Circulation 2005, 111:2927-2934.
13. Du Y., et al. GSTT1 null genotype contributes to coronary heart disease risk: a meta-analysis. Mol. Biol. Rep. 2012, 39:8571-8579.
14. Friedewald W.T., et al. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 1972, 18:499-502.
15. Fuster V., et al. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N. Engl. J. Med. 1992, 326:242-250.
16. Garte S., et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol. Biomarkers Prev. 2001, 10:1239-1248.
17. Gibbons R.J., et al. ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation 2002, 106:1883-1892.
18. Gilliland F.D., et al. Glutathione S-transferase P1 and NADPH quinone oxidoreductase polymorphisms are associated with aberrant promoter methylation of P16(INK4a) and O(6)-methylguanine-DNA methyltransferase in sputum. Cancer Res. 2002, 62:2248-2252.
19. Gordon T., Kannel W.B. Multiple risk functions for predicting coronary heart disease: the concept, accuracy, and application. Am. Heart J. 1982, 103:1031-1039.
20. Gordon T., et al. Diabetes, blood lipids, and the role of obesity in coronary heart disease risk for women. The Framingham study. Ann. Intern. Med. 1977, 87:393-397.
21. Grundy S.M., et al. Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association. Circulation 1998, 97:1876-1887.
22. Habdous M., et al. Glutathione S-transferases genetic polymorphisms and human diseases: overview of epidemiological studies. Ann. Biol. Clin. (Paris) 2004, 62:15-24.
23. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 2005, 352:1685-1695.
24. Huang C.Y., et al. The GST T1 and CYP2E1 genotypes are possible factors causing vinyl chloride induced abnormal liver function. Arch. Toxicol. 1997, 71:482-488.
25. Kannel W.B., McGee D.L. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care 1979, 2:120-126.
26. Ketterer B. Protective role of glutathione and glutathione transferases in mutagenesis and carcinogenesis. Mutat. Res. 1988, 202:343-361.
27. Komiya Y., et al. Human glutathion S-transferase A1 polymorphism and susceptibility to urothelial cancer in the Japanese population. Cancer Lett. 2005, 221:55-59.
28. Komiya Y., et al. Human glutathione S-transferase A1, T1, M1, and P1 polymorphisms and susceptibility to prostate cancer in the Japanese population. J. Cancer Res. Clin. Oncol. 2005, 131:238-242.
29. Lakier J.B. Smoking and cardiovascular disease. Am. J. Med. 1992, 93:8S-12S.
30. Landi S. Mammalian class theta GST and differential susceptibility to carcinogens: a review. Mutat. Res. 2000, 463:247-283.
31. Li X., et al. AGT gene polymorphisms (M235T, T174M) are associated with coronary heart disease in a Chinese population. J. Renin Angiotensin Aldosterone Syst. 2012, http://jra.sagepub.com/content/early/2012/07/12/1470320312452029.
32. Libby P., Theroux P. Pathophysiology of coronary artery disease. Circulation 2005, 111:3481-3488.
33. MacLeod S., et al. Polymorphisms of CYP1A1 and GSTM1 influence the in vivo function of CYP1A2. Mutat. Res. 1997, 376:135-142.
34. Mannervik B., et al. Nomenclature for human glutathione transferases. Biochem. J. 1992, 282(Pt 1):305-306.
35. Maxwell S.R. Coronary artery disease-free radical damage, antioxidant protection and the role of homocysteine. Basic Res. Cardiol. 2000, 95(Suppl. 1):I65-I71.
36. Morrison A.C., et al. Evaluating the context-dependent effect of family history of stroke in a genome scan for hypertension. Stroke 2003, 34:1170-1175.
37. Murry C.E., et al. Monoclonality of smooth muscle cells in human atherosclerosis. Am. J. Pathol. 1997, 151:697-705.
38. Nilsson P.M., et al. Population-attributable risk of coronary heart disease risk factors during long-term follow-up: the Malmo Preventive Project. J. Intern. Med. 2006, 260:134-141.
39. Norppa H. Genetic polymorphisms and chromosome damage. Int. J. Hyg. Environ. Health 2001, 204:31-38.
40. Norskov M.S., et al. Copy number variation in glutathione S-transferases M1 and T1 and ischemic vascular disease: four studies and meta-analyses. Circ. Cardiovasc. Genet. 2011, 4:418-428.
41. Pemble S., et al. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem. J. 1994, 300(Pt 1):271-276.
42. Penn A., Snyder C. Arteriosclerotic plaque development is 'promoted' by polynuclear aromatic hydrocarbons. Carcinogenesis 1988, 9:2185-2189.
43. Phulukdaree A., et al. GST polymorphisms and early-onset coronary artery disease in young South African Indians. S. Afr. Med. J. 2012, 102:627-630.
44. Pickett C.B., Lu A.Y. Glutathione S-transferases: gene structure, regulation, and biological function. Annu. Rev. Biochem. 1989, 58:743-764.
45. Pontremoli R., et al. Genetic polymorphism of the renin-angiotensin system and organ damage in essential hypertension. Kidney Int. 2000, 57:561-569.
46. Ramprasath T., et al. Potential risk modifications of GSTT1, GSTM1 and GSTP1 (glutathione-S-transferases) variants and their association to CAD in patients with type-2 diabetes. Biochem. Biophys. Res. Commun. 2011, 407:49-53.
47. Randerath E., et al. Tissue distribution of covalent DNA damage in mice treated dermally with cigarette 'tar': preference for lung and heart DNA. Carcinogenesis 1988, 9:75-80.
48. Schachinger V., et al. A positive family history of premature coronary artery disease is associated with impaired endothelium-dependent coronary blood flow regulation. Circulation 1999, 100:1502-1508.
49. Seidegard J., et al. Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc. Natl. Acad. Sci. U. S. A. 1988, 85:7293-7297.
50. Turkanoglu A., et al. Association analysis of GSTT1, GSTM1 genotype polymorphisms and serum total GST activity with ischemic stroke risk. Neurol. Sci. 2010, 31:727-734.
51. Ueno T., et al. Influence of genetic polymorphisms in oxidative stress related genes and smoking on plasma MDA-LDL, soluble CD40 ligand, E-selectin and soluble ICAM1 levels in patients with coronary artery disease. Med. Sci. Monit. 2009, 15:CR341-CR348.
52. Wang L.S., et al. Association of GSTM1 and GSTT1 gene polymorphisms with coronary artery disease in relation to tobacco smoking. Clin. Chem. Lab. Med. 2008, 46:1720-1725.
53. Wang J., et al. Genetic polymorphisms of glutathione S-transferase genes GSTM1, GSTT1 and risk of coronary heart disease. Mutagenesis 2010, 25:365-369.
54. Watson M.A., et al. Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis 1998, 19:275-280.
55. Wilson M.H., et al. Association between the risk of coronary artery disease in South Asians and a deletion polymorphism in glutathione S-transferase M1. Biomarkers 2003, 8:43-50.
56. Yeh C.C., et al. Polymorphisms of cytochrome P450 1A1, cigarette smoking and risk of coronary artery disease. Mutat. Res. 2009, 667:77-81.